Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.6%

276 terminated/withdrawn out of 4202 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

12%

502 trials in Phase 3/4

Results Transparency

34%

1055 of 3065 completed trials have results

Key Signals

490 recruiting1055 with results206 terminated70 withdrawn

Enrollment Performance

Analytics

N/A

1289(49.2%)

Phase 2

489(18.7%)

Phase 3

375(14.3%)

Phase 1

262(10.0%)

Phase 4

127(4.8%)

Early Phase 1

77(2.9%)

2619Total

N/A(1289)

Phase 2(489)

Phase 3(375)

Phase 1(262)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4202)

Showing 20 of 4202 trials

NCT00001204Completed

Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers

Role: lead

NCT07715890Not ApplicableNot Yet Recruiting

Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia

Role: lead

NCT05719714Phase 1Active Not Recruiting

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Role: collaborator

NCT01778569Completed

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

Role: lead

NCT04664478Completed

Gene First Approach to Connective Tissue Disease

Role: lead

NCT07074145Not ApplicableRecruiting

WEAVE NM: Heart Health and Nutrition for Life

Role: collaborator

NCT05372627Not Yet Recruiting

NHLBI-Emory Advanced Cardiac CT Reconstruction

Role: lead

NCT07137455Not ApplicableEnrolling By Invitation

EDEN Intracardiac Electrogram Recording and Classifying System

Role: lead

NCT00081523Recruiting

Natural History of Sickle Cell Disease

Role: lead

NCT00047996Enrolling By Invitation

Blood Collection for Research Related to Certain Diseases Involving Blood Vessels

Role: lead

NCT06280820Enrolling By Invitation

Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

Role: lead

NCT05600426Phase 3Active Not Recruiting

A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Role: collaborator

NCT03649178Not ApplicableCompleted

Dietary Salt in Rheumatoid Arthritis

Role: collaborator

NCT01169259Phase 3Active Not Recruiting

Vitamin D and Omega-3 Trial (VITAL)

Role: collaborator

NCT06940752Not ApplicableEnrolling By Invitation

VINTAGE (Ventricular Intramyocardial Navigation for Tachycardia Ablation Guided by Electrograms) Using Commercial Off-The-Shelf (COTS) Catheters

Role: lead

NCT06948097Phase 1Not Yet Recruiting

Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

Role: lead

NCT05724121Recruiting

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Role: lead

NCT07613099Phase 3Recruiting

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

Role: lead

NCT00038727Phase 3Completed

Diabetes Prevention Program Outcomes Study

Role: collaborator

NCT07566494Phase 1Recruiting

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

Role: lead